Total Gut Health 15
Natural health product licensed in Canada
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80070963
- Status
- Active licence
- Licence date
- 8 July 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Daucus carota Source : Daucus Carota - Racine | 15.4 milligramme | Not calculated |
| Lactococcus lactis Source : Cellule entière | 0.75 Milliards d'UFC | Not calculated |
| Isomaltooligosaccharides Source : Isomaltooligosaccharides | 200 milligramme | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 1.5 Milliards d'UFC | Not calculated |
| Portulaca oleracea Source : Plante | 46.1 milligramme | Not calculated |
| Solanum lycopersicum Source : Chair (fruit) | 15.4 milligramme | Not calculated |
| Nigella sativa Source : Graine(s) | 15.4 milligramme | Not calculated |
| Lactobacillus reuteri Source : Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 3.75 Milliards d'UFC | Not calculated |
| Phyllanthus emblica Source : Fruit | 15.4 milligramme | Not calculated |
| Lactobacillus casei Source : Cellule entière | 0.75 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 0.45 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 0.75 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : Cellule entière | 0.45 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 6 Milliards d'UFC | Not calculated |
| Linum usitatissimum Source : Graine(s) | 153.9 milligramme | Not calculated |
| Oryza sativa Source : Seed Bran | 76.9 milligramme | Not calculated |
| Brassica oleracea var. viridis Source : Plante entière | 15.4 milligramme | Not calculated |
| Hippophae rhamnoides Source : Fruit | 15.4 milligramme | Not calculated |
| Theobroma cacao Source : Graine(s) | 15.4 milligramme | Not calculated |
| Olea europaea Source : Fruit | 15.4 milligramme | Not calculated |
Non-medicinal ingredients
Acide ascorbique, Hypromellose, Amidon de maïs, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 6 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of probiotics Helps support intestinal/gastrointestinal health Could promote a favourable gut flora Source of antioxidants for the maintenance of good health Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070963
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Daucus carota
Read the warning, when it applies and the studies cited
CARROT - DAUCUS CAROTA SUBSP. SATIVUS
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 6,000 μg of beta-carotene, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Phyllanthus emblica
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Linum usitatissimum
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Olea europaea
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.